FIELD: chemistry.
SUBSTANCE: invention relates to the compound with formula (I) or to its tartrate salt. The invention also relates to application of the composition as well as the method of inhibiting of monoamine receptor activation to inverse agonist and anti-dyskinesia agent in the combination with inverse agonist.
EFFECT: production of the new biologically active compound having inverse agonist activity of serotonin receptor.
54 cl, 7 ex, 3 tbl
Authors
Dates
2008-08-27—Published
2004-01-15—Filed